Clement Opoku-Temeng

1PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Apr 03, 2018
Alkynylnicotinamide-Based Compounds as ABL1 Inhibitors with Potent Activities against Drug-Resistant CML Harboring ABL1(T315I) Mutant Kinase.

Elizabeth A Larocque, N Naganna, Clement Opoku-Temeng

Pageof 1

Frequent Collaborators

1 joint publications

Herman O Sintim